Pierre Fabre Laboratories on the global stage at two international congresses in September: ESMO and EADV
Pierre Fabre Laboratories’ mission is to innovate constantly, particularly in the fields of oncology and dermatology. This mission is accomplished alongside healthcare professionals, the company’s day-to-day partners. Driven by a constant desire to share expertise and present the company’s latest therapeutic innovations, Pierre Fabre teams are taking part in two major events in September: ESMO and EADV.
ESMO in Barcelona: At the heart of advances in oncology with Pierre Fabre
From September 13 to 17, Pierre Fabre Laboratories will take center stage at ESMO, the leading European oncology congress. It will present an interactive symposium dedicated to the management of patients with BRAF V600E-mutant metastatic colorectal cancer. This event is designed to be interactive (oncologists will vote for case studies on stand 407).
The main interests of oncologists will be addressed in detail during the symposium, encouraging in-depth, practical knowledge sharing.
This participation reflects Pierre Fabre Laboratories’ ongoing commitment to finding innovative solutions in the fight against cancer, reflected in an investment of over 50% of our R&D budget in this field, with a particular focus on precision medicine.
EADV in Amsterdam: the dermatological revolution by Pierre Fabre
From September 25 to 28, innovations in dermatology will be under the spotlight at EADV, where Pierre Fabre will reaffirm its leadership in this field. Pierre Fabre Laboratories strives to transform dermatological care and share its latest advances with industry professionals.
Pierre Fabre Laboratories works with the medical ecosystem to provide patients with holistic support throughout their care pathway.
Join us to become an agent of change in healthcare, and to celebrate together the progress we are making for patients worldwide.
